endo_001:
  morphology: CARCINOMA_OTHER
  descriptive_name: Papillary thyroid carcinoma
  biomarker_profile: "BRAF V600E mutation detected. RET/PTC rearrangement negative."

endo_002:
  morphology: NEUROENDOCRINE
  descriptive_name: Adrenal pheochromocytoma
  biomarker_profile: "No targetable alterations identified on limited molecular panel."

endo_003:
  morphology: CARCINOMA_OTHER
  descriptive_name: Follicular thyroid cancer
  biomarker_profile: "NRAS Q61R mutation positive. BRAF wild-type. PAX8/PPARG fusion not detected. TP53 p.R273H mutation identified."

endo_004:
  morphology: CARCINOMA_OTHER
  descriptive_name: PTC
  biomarker_profile: "RET fusion positive"

endo_005:
  morphology: NEUROENDOCRINE
  descriptive_name: Pancreatic neuroendocrine tumor
  biomarker_profile: "Molecular testing not performed due to insufficient tissue."

endo_006:
  morphology: CARCINOMA_OTHER
  descriptive_name: Medullary thyroid carcinoma
  biomarker_profile: "Germline RET mutation c.1900T>C (p.C634R) detected, consistent with MEN2A syndrome. Somatic testing: HRAS negative, KRAS negative."

endo_007:
  morphology: CARCINOMA_OTHER
  descriptive_name: Adrenocortical carcinoma
  biomarker_profile: "TP53 mutation identified (c.818G>A, p.R273H). MSI stable."

endo_008:
  morphology: CARCINOMA_OTHER
  descriptive_name: Thyroid ca
  biomarker_profile: "BRAF+"

endo_009:
  morphology: NEUROENDOCRINE
  descriptive_name: Well-differentiated NET of unknown primary
  biomarker_profile: "No actionable mutations detected on comprehensive genomic profiling."

endo_010:
  morphology: CARCINOMA_OTHER
  descriptive_name: Anaplastic thyroid carcinoma
  biomarker_profile: "BRAF V600E positive by IHC. TP53 R248W mutation. NTRK fusion testing negative by NGS. KRAS wild-type. TMB 8.2 mutations/Mb."

endo_011:
  morphology: CARCINOMA_OTHER
  descriptive_name: Hurthle cell carcinoma
  biomarker_profile: "NGS panel: NRAS negative, HRAS negative, KRAS negative, BRAF negative, RET negative"

endo_012:
  morphology: CARCINOMA_OTHER
  descriptive_name: FTC
  biomarker_profile: "NRAS codon 61 mut detected"

endo_013:
  morphology: NEUROENDOCRINE
  descriptive_name: Paraganglioma
  biomarker_profile: "Germline SDHB mutation identified. Recommend genetic counseling."

endo_014:
  morphology: CARCINOMA_OTHER
  descriptive_name: Papillary thyroid cancer with tall cell features
  biomarker_profile: "BRAF V600E mutation detected by PCR. RET rearrangement not detected. NTRK1 fusion negative. TP53 wild-type on sequencing."

endo_015:
  morphology: CARCINOMA_OTHER
  descriptive_name: MTC
  biomarker_profile: "RET M918T"

endo_016:
  morphology: NEUROENDOCRINE
  descriptive_name: Adrenal neuroblastoma
  biomarker_profile: "Limited molecular profiling performed - no targetable alterations."

endo_017:
  morphology: CARCINOMA_OTHER
  descriptive_name: Poorly differentiated thyroid carcinoma
  biomarker_profile: "Comprehensive genomic profiling reveals: BRAF V600E mutation, TP53 Y220C mutation, NRAS wild-type, KRAS wild-type, HRAS wild-type, RET fusion negative, NTRK1/2/3 fusions all negative."

endo_018:
  morphology: CARCINOMA_OTHER
  descriptive_name: Thyroid adenocarcinoma
  biomarker_profile: "No mutations detected"

endo_019:
  morphology: NEUROENDOCRINE
  descriptive_name: Functioning pNET
  biomarker_profile: "Molecular analysis deferred - clinical management based on functional status."

endo_020:
  morphology: CARCINOMA_OTHER
  descriptive_name: Papillary microcarcinoma
  biomarker_profile: "BRAF testing: V600E mutation present"

endo_021:
  morphology: CARCINOMA_OTHER
  descriptive_name: ACC
  biomarker_profile: "p53 IHC shows complete loss of expression"

endo_022:
  morphology: CARCINOMA_OTHER
  descriptive_name: Differentiated thyroid cancer
  biomarker_profile: "NTRK3 gene fusion detected by RNA sequencing. BRAF V600E negative. RET fusion negative."

endo_023:
  morphology: NEUROENDOCRINE
  descriptive_name: G2 neuroendocrine tumor
  biomarker_profile: "No specific molecular testing requested by treating physician."

endo_024:
  morphology: CARCINOMA_OTHER
  descriptive_name: Metastatic thyroid carcinoma
  biomarker_profile: "RET/PTC1 rearrangement positive by FISH. BRAF mutation analysis: wild-type. NRAS, HRAS, KRAS: all wild-type."

endo_025:
  morphology: CARCINOMA_OTHER
  descriptive_name: Thyroid
  biomarker_profile: "BRAF neg"

endo_026:
  morphology: NEUROENDOCRINE
  descriptive_name: Carcinoid tumor
  biomarker_profile: "Molecular profiling not indicated for this well-differentiated tumor."

endo_027:
  morphology: CARCINOMA_OTHER
  descriptive_name: Recurrent PTC
  biomarker_profile: "Previous BRAF V600E positive (2021). Current biopsy: RET fusion negative, NTRK testing negative, TP53 p.G245S mutation newly identified."

endo_028:
  morphology: CARCINOMA_OTHER
  descriptive_name: Follicular variant of papillary thyroid carcinoma
  biomarker_profile: "NRAS Q61K mutation. BRAF V600E: not detected."

endo_029:
  morphology: CARCINOMA_OTHER
  descriptive_name: Adrenal cortical neoplasm
  biomarker_profile: "TP53 c.743G>A (p.R248Q)"

endo_030:
  morphology: NEUROENDOCRINE
  descriptive_name: High-grade neuroendocrine carcinoma
  biomarker_profile: "Insufficient tissue for molecular analysis."

endo_031:
  morphology: CARCINOMA_OTHER
  descriptive_name: PDTC
  biomarker_profile: "Molecular testing: BRAF V600E positive, TP53 R175H positive, NRAS negative, RET wild-type"

endo_032:
  morphology: CARCINOMA_OTHER
  descriptive_name: Thyroid cancer, NOS
  biomarker_profile: "Comprehensive panel pending."

endo_033:
  morphology: NEUROENDOCRINE
  descriptive_name: Atypical carcinoid
  biomarker_profile: "No actionable alterations on limited NGS panel."

endo_034:
  morphology: CARCINOMA_OTHER
  descriptive_name: Medullary thyroid
  biomarker_profile: "Somatic RET M918T mutation identified. Germline RET testing negative (sporadic MTC)."

endo_035:
  morphology: CARCINOMA_OTHER
  descriptive_name: ATC
  biomarker_profile: "BRAF V600E+, TP53+, KRAS-, multiple other alterations"

endo_036:
  morphology: NEUROENDOCRINE
  descriptive_name: Insulinoma
  biomarker_profile: "Molecular characterization not performed - surgically resected."

endo_037:
  morphology: CARCINOMA_OTHER
  descriptive_name: Papillary thyroid carcinoma, classical variant
  biomarker_profile: "BRAF codon 600 mutation detected (c.1799T>A). RET/PTC rearrangement: not detected. NRAS: wild-type. TP53: no pathogenic variants identified."

endo_038:
  morphology: CARCINOMA_OTHER
  descriptive_name: Thyroid malignancy
  biomarker_profile: "RET fusion positive (CCDC6-RET)"

endo_039:
  morphology: CARCINOMA_OTHER
  descriptive_name: Oncocytic thyroid carcinoma
  biomarker_profile: "All tested markers negative (BRAF, NRAS, HRAS, KRAS, RET)"

endo_040:
  morphology: NEUROENDOCRINE
  descriptive_name: Pheochromocytoma
  biomarker_profile: "VHL germline mutation detected. Recommend family screening."

endo_041:
  morphology: CARCINOMA_OTHER
  descriptive_name: Minimally invasive follicular thyroid carcinoma
  biomarker_profile: "HRAS Q61R mutation present. BRAF and RET negative."

endo_042:
  morphology: CARCINOMA_OTHER
  descriptive_name: Thyroid adenoca
  biomarker_profile: "NTRK1 fusion+"

endo_043:
  morphology: NEUROENDOCRINE
  descriptive_name: GEP-NET
  biomarker_profile: "No molecular testing performed."

endo_044:
  morphology: CARCINOMA_OTHER
  descriptive_name: Columnar cell variant PTC
  biomarker_profile: "BRAF V600E mutation detected by IHC and confirmed by sequencing. TP53 wild-type. RET and NTRK fusions not detected."

endo_045:
  morphology: CARCINOMA_OTHER
  descriptive_name: Medullary ca
  biomarker_profile: "RET C634Y (germline)"

endo_046:
  morphology: CARCINOMA_OTHER
  descriptive_name: Adrenocortical adenoma vs carcinoma
  biomarker_profile: "TP53 mutation present (pathogenic variant c.524G>A)"

endo_047:
  morphology: NEUROENDOCRINE
  descriptive_name: Non-functioning NET
  biomarker_profile: "Molecular markers not evaluated."

endo_048:
  morphology: CARCINOMA_OTHER
  descriptive_name: Widely invasive FTC
  biomarker_profile: "PAX8/PPARG fusion detected by FISH. NRAS, HRAS, KRAS mutations: not detected. BRAF: wild-type."

endo_049:
  morphology: CARCINOMA_OTHER
  descriptive_name: Thyroid cancer
  biomarker_profile: "BRAF V600E detected"

endo_050:
  morphology: NEUROENDOCRINE
  descriptive_name: Metastatic neuroendocrine tumor
  biomarker_profile: "Limited tissue - molecular testing unsuccessful."

endo_051:
  morphology: CARCINOMA_OTHER
  descriptive_name: Radioiodine-refractory DTC
  biomarker_profile: "NGS results: BRAF V600E positive, TP53 R282W positive, NRAS negative, KRAS negative, RET fusion negative, NTRK1/2/3 fusions negative, TMB 3.8 mut/Mb."

endo_052:
  morphology: CARCINOMA_OTHER
  descriptive_name: PTC, follicular variant
  biomarker_profile: "RAS mutation identified"

endo_053:
  morphology: CARCINOMA_OTHER
  descriptive_name: Adrenal carcinoma
  biomarker_profile: "TP53 R175H mutation"

endo_054:
  morphology: NEUROENDOCRINE
  descriptive_name: Well-differentiated NET, grade 1
  biomarker_profile: "No molecular abnormalities detected."

endo_055:
  morphology: CARCINOMA_OTHER
  descriptive_name: Encapsulated follicular variant PTC
  biomarker_profile: "NRAS Q61R positive. BRAF V600E negative. RET/PTC negative."

endo_056:
  morphology: CARCINOMA_OTHER
  descriptive_name: Thyroid carcinoma, poorly differentiated
  biomarker_profile: "Multiple mutations: BRAF+, TP53+, HRAS+"

endo_057:
  morphology: NEUROENDOCRINE
  descriptive_name: Gastrinoma
  biomarker_profile: "Genetic testing for MEN1 syndrome pending."

endo_058:
  morphology: CARCINOMA_OTHER
  descriptive_name: Solid variant papillary thyroid carcinoma
  biomarker_profile: "RET/PTC3 rearrangement detected. BRAF V600E mutation not identified. TP53 analysis: no mutations detected."

endo_059:
  morphology: CARCINOMA_OTHER
  descriptive_name: MTC, hereditary
  biomarker_profile: "Germline RET C618R"

endo_060:
  morphology: CARCINOMA_OTHER
  descriptive_name: Cortical carcinoma
  biomarker_profile: "TP53 loss demonstrated by IHC"

endo_061:
  morphology: NEUROENDOCRINE
  descriptive_name: Typical carcinoid tumor
  biomarker_profile: "No genetic alterations identified on targeted panel."

endo_062:
  morphology: CARCINOMA_OTHER
  descriptive_name: Insular thyroid carcinoma
  biomarker_profile: "Molecular profiling reveals NRAS Q61K mutation and TP53 R248Q mutation. BRAF wild-type."

endo_063:
  morphology: CARCINOMA_OTHER
  descriptive_name: Papillary microca
  biomarker_profile: "BRAF mutation present"

endo_064:
  morphology: NEUROENDOCRINE
  descriptive_name: ACTH-secreting pituitary adenoma
  biomarker_profile: "Molecular testing not clinically indicated."

endo_065:
  morphology: CARCINOMA_OTHER
  descriptive_name: Metastatic anaplastic thyroid cancer
  biomarker_profile: "Extensive molecular alterations: BRAF V600E+, TP53 R273C+, KRAS G12D+, NTRK fusion-, RET fusion-, TMB 15.3 mut/Mb (intermediate)."

endo_066:
  morphology: CARCINOMA_OTHER
  descriptive_name: DTC
  biomarker_profile: "NTRK fusion positive"

endo_067:
  morphology: CARCINOMA_OTHER
  descriptive_name: Adrenal adenocarcinoma
  biomarker_profile: "p53 mutation detected"

endo_068:
  morphology: NEUROENDOCRINE
  descriptive_name: Multiple endocrine neoplasia syndrome-associated NET
  biomarker_profile: "Germline MEN1 mutation confirmed."

endo_069:
  morphology: CARCINOMA_OTHER
  descriptive_name: Diffuse sclerosing variant PTC
  biomarker_profile: "RET/PTC1 rearrangement positive. BRAF V600E negative. TP53 wild-type. NRAS, HRAS, KRAS all negative."

endo_070:
  morphology: CARCINOMA_OTHER
  descriptive_name: Thyroid
  biomarker_profile: "No mutations"

endo_071:
  morphology: NEUROENDOCRINE
  descriptive_name: Glucagonoma
  biomarker_profile: "Molecular studies not performed - clinical diagnosis."

endo_072:
  morphology: CARCINOMA_OTHER
  descriptive_name: Hobnail variant PTC
  biomarker_profile: "BRAF V600E strongly positive by IHC. Molecular confirmation: BRAF c.1799T>A. TP53 p.Y220C also detected."

endo_073:
  morphology: CARCINOMA_OTHER
  descriptive_name: Sporadic medullary thyroid carcinoma
  biomarker_profile: "RET M918T somatic mutation"

endo_074:
  morphology: CARCINOMA_OTHER
  descriptive_name: ACC (adrenal)
  biomarker_profile: "TP53 pathogenic variant identified"

endo_075:
  morphology: NEUROENDOCRINE
  descriptive_name: Low-grade NET
  biomarker_profile: "Tissue insufficient for molecular analysis."

endo_076:
  morphology: CARCINOMA_OTHER
  descriptive_name: Cribriform-morular thyroid carcinoma
  biomarker_profile: "APC gene mutation detected (associated with FAP). BRAF negative. RET negative."

endo_077:
  morphology: CARCINOMA_OTHER
  descriptive_name: Thyroid neoplasm
  biomarker_profile: "HRAS+"

endo_078:
  morphology: NEUROENDOCRINE
  descriptive_name: VIPoma
  biomarker_profile: "No targetable mutations identified."

endo_079:
  morphology: CARCINOMA_OTHER
  descriptive_name: Warthin-like PTC
  biomarker_profile: "BRAF V600E mutation present. RET/PTC rearrangement absent. NRAS wild-type."

endo_080:
  morphology: CARCINOMA_OTHER
  descriptive_name: Hereditary MTC
  biomarker_profile: "RET germline mutation c.2753T>C (p.M918T), de novo"

endo_081:
  morphology: CARCINOMA_OTHER
  descriptive_name: Adrenal cortical malignancy
  biomarker_profile: "Next-generation sequencing: TP53 R273H"

endo_082:
  morphology: NEUROENDOCRINE
  descriptive_name: Intermediate-grade neuroendocrine neoplasm
  biomarker_profile: "Molecular testing not pursued."

endo_083:
  morphology: CARCINOMA_OTHER
  descriptive_name: Noninvasive follicular thyroid neoplasm with papillary-like nuclear features
  biomarker_profile: "NRAS codon 61 mutation. BRAF and RET negative."

endo_084:
  morphology: CARCINOMA_OTHER
  descriptive_name: Thyroid malignancy, unspecified
  biomarker_profile: "KRAS G12V"

endo_085:
  morphology: NEUROENDOCRINE
  descriptive_name: Somatostatinoma
  biomarker_profile: "No molecular diagnostics performed."

endo_086:
  morphology: CARCINOMA_OTHER
  descriptive_name: Clear cell variant PTC
  biomarker_profile: "Molecular testing shows BRAF wild-type, RET/PTC negative, NRAS Q61R mutation detected, TP53 negative."

endo_087:
  morphology: CARCINOMA_OTHER
  descriptive_name: MTC with amyloid
  biomarker_profile: "Somatic RET mutation"

endo_088:
  morphology: CARCINOMA_OTHER
  descriptive_name: Functioning adrenocortical carcinoma
  biomarker_profile: "TP53 c.818G>T (p.R273L) mutation identified"

endo_089:
  morphology: NEUROENDOCRINE
  descriptive_name: Ectopic ACTH-producing NET
  biomarker_profile: "Limited molecular panel negative."

endo_090:
  morphology: CARCINOMA_OTHER
  descriptive_name: Spindle cell variant PTC
  biomarker_profile: "BRAF V600E detected by ddPCR. RET and NTRK1/2/3 fusions all negative by RNA seq. TP53 p.R175H mutation present."

endo_091:
  morphology: CARCINOMA_OTHER
  descriptive_name: Familial medullary thyroid cancer
  biomarker_profile: "RET C611W germline"

endo_092:
  morphology: NEUROENDOCRINE
  descriptive_name: High-grade NEC
  biomarker_profile: "QNS for molecular testing"

endo_093:
  morphology: CARCINOMA_OTHER
  descriptive_name: Macrofollicular variant FTC
  biomarker_profile: "HRAS Q61K mutation detected. PAX8/PPARG fusion negative."

endo_094:
  morphology: CARCINOMA_OTHER
  descriptive_name: Dedifferentiated thyroid carcinoma
  biomarker_profile: "Complex molecular profile: BRAF V600E+, TP53 double hit (R273H and Y163C), NRAS-, KRAS-, RET fusion-, high TMB (18.5 mut/Mb)"

endo_095:
  morphology: CARCINOMA_OTHER
  descriptive_name: Thyroid adenocarcinoma, NOS
  biomarker_profile: "RET rearrangement detected"

endo_096:
  morphology: NEUROENDOCRINE
  descriptive_name: Catecholamine-secreting paraganglioma
  biomarker_profile: "SDHD germline mutation identified."

endo_097:
  morphology: CARCINOMA_OTHER
  descriptive_name: Papillary thyroid carcinoma with squamous metaplasia
  biomarker_profile: "BRAF V600E positive (strong, diffuse staining by IHC). Confirmatory molecular testing: BRAF c.1799T>A. TP53 and RET wild-type."

endo_098:
  morphology: CARCINOMA_OTHER
  descriptive_name: MEN2B-associated MTC
  biomarker_profile: "Germline RET M918T mutation"

endo_099:
  morphology: CARCINOMA_OTHER
  descriptive_name: Adrenal oncocytic neoplasm
  biomarker_profile: "TP53 mutation detected by NGS"

endo_100:
  morphology: NEUROENDOCRINE
  descriptive_name: Metastatic well-differentiated NET, unknown primary
  biomarker_profile: "Comprehensive genomic profiling: no actionable alterations identified across 324 genes tested."